Proud to share our KDIGO Controversies Conference report on Kidney Disease and Heart Failure, published simultaneously in Kidney International and JACC: Heart Failure.
Huge thanks to @NishaKidneyDoc who co-led this with me, and the entire @goKDIGO team! 🙏
Cardiac amyloidosis is underdiagnosed and patients often present too late.
As a cardiologist and co-founder of @Us2ai, this is the problem I have always wanted AI to solve.
Sharing our new paper in Circ Cardiovascular Imaging validating our automated CA detection model!
🫀 Honored to be featured on Hawaii News Now ahead of #WorldHeartDay to talk about protecting our hearts.
❤️ 1 in 3 of us will die of heart disease — but most cases are preventable.
🎥 Watch the interview: https://t.co/G0YZVmRCqm
It is with great honor that I was recognised at this year's National Medical Excellence Awards in Singapore and awarded the National Outstanding Clinician Scientist Award 2025!
Honored to be featured discussing the SURMOUNT-MMO trial, the first cardiovascular outcomes study of tirzepatide in patients with obesity but without diabetes.
🚀 𝐍𝐞𝐰 𝐔𝐬𝐞 𝐂𝐚𝐬𝐞 𝐨𝐟 𝐀𝐈 𝐄𝐜𝐡𝐨 𝐟𝐫𝐨𝐦 𝐀𝐒𝐄 2025
We’re excited to share a presentation that featured the @us2_ai software in a novel application: 𝑨𝑰 𝑬𝒄𝒉𝒐𝒄𝒂𝒓𝒅𝒊𝒐𝒈𝒓𝒂𝒑𝒉𝒚 𝒇𝒐𝒓 𝑫𝒊𝒂𝒔𝒕𝒐𝒍𝒊𝒄 𝑬𝒗𝒂𝒍𝒖𝒂𝒕𝒊𝒐𝒏 𝒊𝒏 𝑷𝒓𝒆𝒐𝒑𝒆𝒓𝒂𝒕𝒊𝒗𝒆 𝑷𝒂𝒕𝒊𝒆𝒏𝒕𝒔.
Traditionally, handheld echo studies have focused on EF or individual diastolic parameters like E/e’. With the evolution of handheld devices equipped with continuous wave Doppler (CWD) and AI automation, comprehensive assessment of left ventricular diastolic dysfunction (LVDD) is now possible.
🫀 Artificial intelligence is rapidly becoming part of cardiovascular medicine, with innovations moving quickly from research into clinical practice.
In a recent Personal Perspectives article in the Netherlands Heart Journal, clinicians from Erasmus Medical Center Rotterdam and Wilhelmina Ziekenhuis Assen share their experiences integrating Us2 into daily echo workflows.
Another inspiring day at #ESCCongress!
Honored to chair the Hotline 2 session with excellent presentations and discussions. Grateful to be part of a community driving innovation in cardiology.
Looking forward to another great day tomorrow!
⌛️Wrapping up Day 2 at #ESCCongress2025!
It’s been a fantastic day connecting with so many of you interested in how our AI-powered echocardiography application can make a difference in clinical practice and research.
A big thank you to everyone who stopped by to learn more and share your thoughts, we truly value all the conversations and connections.
If you haven’t had the chance yet, make sure to stop by tomorrow to speak with our team. We’d love to connect!
Day 1 at #ESCCongress has been full of energy, and inspiring science. Always a highlight to see how much innovation is happening in cardiology and to reconnect with so many familiar faces. Looking forward to the next few days of learning and discussions here in Madrid!
📚 We hope you’ve learnt as much as we did from this Nature Reviews Cardiology review article.
Read it here: https://t.co/bUQKobQCIr
💬 If you’re ready to start exploring AI in echocardiography for your clinical workflow, contact us for a demo today!
https://t.co/LR5so3R0R3 Becomes One of the First SaMDs in Singapore to Achieve CLS(MD) Certification ✅
We’re excited to share that https://t.co/LR5so3R0R3 has joined Singapore’s Cybersecurity Labelling Scheme for Medical Devices (CLS-MD) certified product list, making us the 9th product in Singapore and among the first few Software as a Medical Device (SaMD) to achieve this certification.
Very pleased to share our review on AI echocardiography in cardiovascular disease management is now published!
I hope this article serves as a resource for continued learning, discussion, and collaboration across the field.
🔗https://t.co/Ue44ZofLpf
✨ https://t.co/LR5so3R0R3 Featured at AI in Clinical Echo Sessions | AFCC 2025 Spotlight
At the recent AI in Clinical Echocardiography session at the Asian Federation of Cardiology Congress (AFCC), Dr. Andy Ko from the Sarawak Heart Center shared an overview of leading AI echo solutions—and featured https://t.co/LR5so3R0R3 in the spotlight.
🧵
💡 Cardiac Amyloidosis Detection with https://t.co/LR5so3R0R3: AI-Based Pattern Recognition
FDA-cleared and CE-marked, https://t.co/LR5so3R0R3 detects cardiac amyloidosis using AI-based pattern recognition—from a single apical 4-chamber (A4C) view.
👀 Curious how the finding appears in the https://t.co/LR5so3R0R3 report? Take a look below!
🧵
🚨 In case you missed it — @us2_ai is now FDA-cleared and CE-marked for Cardiac Amyloidosis detection!
We’re the first and only platform to combine:
1️⃣ AI-based pattern recognition
2️⃣ Fully explainable, guideline-based automated reporting using echo measurements
All in a single solution. 🫀
🧵👇
🌍 Did you know?
https://t.co/m6D3Ako4JB is regulatory cleared in over 30 countries worldwide — enabling fast, accurate, and scalable echocardiography analysis for clinicians and researchers across the globe.
🧵👇
📍 Where will the https://t.co/LR5so3R0R3 team be this week?
Heading to the ASEAN Federation of Cardiology Congress? Don’t miss your chance to connect with us on-site!
We’ll also be at the Digital Health in Heart Disease Care Pre-Congress on July 17, where we’re joining the panel:
🗣 “Digital Health in Clinical Cardiology – Where Are We Now?”
🧵👇
✈️ This week, the https://t.co/m6D3Ako4JB team flew in from all corners of the world to spend a few days together — in person!
From strategy sessions to spontaneous laughs and team dinners, it was a chance to reflect, connect, and align.👇🏻